Exclusive Investor Perks. Learn More →
Limited-Time Offer: Earn Up To 18% Bonus Shares Until 01/08
Limited-Time Offer: Earn Up To 20% Bonus Shares Until 12/09
00
Days
00
Hrs
00
Mins
00
Secs

Oxeia Biopharmaceutical Investment Opportunity

Investment Details
Share Price:
USD
Min Investment:
$1,000.14*
USD
Offering Type:
Equity
Asset Type:
Common Stock
Form C
SEC Filings
Form CRS
Perks
Please note that while bonus shares above won’t be visible at checkout, they will be added to your account after your purchase.
Invest
$2,500+
Receive
5%
Bonus Shares
Invest
$5,000+
Receive
7%
Bonus Shares
Invest
$10,000+
Receive
9%
Bonus Shares
Invest
$25,000+
Receive
15%
Bonus Shares
Invest
$1,000+
Receive
3%
Bonus Shares
Invest
$2,500+
Receive
5%
+3% until 01/08
Bonus Shares
Invest
$5,000+
Receive
7%
+3% until 01/08
Bonus Shares
Invest
$10,000+
Receive
9%
+3% until 01/08
Bonus Shares
Invest
$25,000+
Receive
15%
+3% until 01/08
Bonus Shares
Invest
$1,000+
Receive
5%
Bonus Shares
Invest
$2,500+
Receive
5%
+5% until 12/09
Bonus Shares
Invest
$5,000+
Receive
7%
+5% until 12/09
Bonus Shares
Invest
$10,000+
Receive
9%
+5% until 12/09
Bonus Shares
Invest
$25,000+
Receive
15%
+5% until 12/09
Bonus Shares
$2,500+
5%
Bonus Shares
$25,000+
15%
Bonus Shares
$5,000+
7%
Bonus Shares
$10,000+
9%
Bonus Shares
$1,000+
3%
Bonus Shares
$2,500+
5%
Bonus Shares
+3% until 01/08
$25,000+
15%
Bonus Shares
+3% until 01/08
$5,000+
7%
Bonus Shares
+3% until 01/08
$10,000+
9%
Bonus Shares
+3% until 01/08
$1,000+
5%
Bonus Shares
$2,500+
5%
Bonus Shares
+5% until 12/09
$25,000+
15%
Bonus Shares
+5% until 12/09
$5,000+
7%
Bonus Shares
+5% until 12/09
$10,000+
9%
Bonus Shares
+5% until 12/09
Additional Information
I consent to receiving reports, promotional emails and other commercial electronic messages from Oxeia Biopharmaceutical or from other service providers on behalf of Oxeia Biopharmaceutical.

Government-required identity & anti-fraud checks secure all transactions. Why Do We Need This?

 

Since this is a financial transaction we are required by regulators like the SEC & US Department of Treasury to perform AML (Anti Money Laundering) & KYC (Know Your Customer) verification in order to avoid money laundering, fraud, and identity theft. 

 

Our broker-dealer, DealMaker Securities, LLC uses a Taxpayer Identification Number (TIN), for example Social Security Number (SSN), Employment Identification Number (EIN), Individual Tax Identification Number (ITIN) to fulfill its responsibilities with its Anti-Money Laundering (AML) Program as required by the Bank Secrecy Act (BSA) and its implementing regulations and FINRA Rule 3310 (AML Compliance Program) by requesting, reviewing, and verifying data and documentation provided during securities transactions, prior to acceptance. 

 

Here’s why they are required for startup investments:

 

1.

Preventing Illegal Activities: Money laundering involves the concealment or disguise of money derived from criminal origins by processing it through a single or series of transactions to make it appear as if it comes from a legal, legitimate source or constitute legitimate assets. Having a verification process, whereby investors are reviewed, checked against governmental databases, and all investment funds are evaluated, startups can feel confident they are protecting themselves from civil and criminal penalties and preventing terrorist financing, drug trafficking, tax evasion, corruption, fraud, and other financial crimes.

 

2.

Identity Verification/Data: KYC processes help collect essential pieces of data and verify the identity and authority of the investors, ensuring that they are indeed who they claim to be and are authorized to process the transaction they seek to make. This protects against identity theft and fraud.

 

3.

Regulatory Compliance: Compliance with AML and KYC requirements is mandatory in many jurisdictions. Failure to comply can lead to severe civil penalties, including heavy fines, and even criminal penalties.